Cholesterol Is Associated with the Presence of a Lipid Core in Carotid Plaque of Asymptomatic, Young-to-Middle-Aged African Americans with and without HIV Infection and Cocaine Use Residing in Inner-City Baltimore, Md., USADu J.a · Wasserman B.A.b · Tong W.c · Chen S.c · Lai S.c · Malhotra S.d · Lai H.b
aDepartment of Emergency Medicine, 301 Hospital, Beijing, China; Departments of bRadiology and cPathology, Johns Hopkins School of Medicine, Baltimore, Md., and dKrannert Institute of Cardiology, Indiana University, Indianapolis, Ind., USA Corresponding Author
H. Lai, PhD, MPH
Department of Radiology, Johns Hopkins School of Medicine
600 N. Wolfe Street
Baltimore, MD 21287 (USA)
Tel. +1 410 955 2216, E-Mail email@example.com
Background: Stroke remains a leading cause of death in the United States. While stroke-related mortality in the USA has declined over the past decades, stroke death rates are still higher for blacks than for whites, even at younger ages. The purpose of this study was to estimate the frequency of a lipid core and explore risk factors for its presence in asymptomatic, young-to-middle-aged urban African American adults recruited from inner-city Baltimore, Md., USA. Methods: Between August 28, 2003, and May 26, 2005, 198 African American participants aged 30-44 years from inner-city Baltimore, Md., were enrolled in an observational study of subclinical atherosclerosis related to HIV and cocaine use. In addition to clinical examinations and laboratory tests, B-mode ultrasound for intima-media thickness of the internal carotid arteries was performed. Among these 198, 52 were selected from the top 30th percentile of maximum carotid intima-media thickness by ultrasound, and high-resolution black blood MRI images were acquired through their carotid plaque before and after the intravenous administration of gadodiamide. Of these 52, 37 with maximum segmental thickness by MRI >1.0 mm were included in this study. Lumen and outer wall contours were defined using semiautomated analysis software. The frequency of a lipid core in carotid plaque was estimated and risk factors for lipid core presence were explored using logistic regression analysis. Results: Of the 37 participants in this study, 12 (32.4%) were women. The mean age was 38.7 ± 4.9 years. A lipid core was present in 9 (17%) of the plaques. Seventy percent of the study participants had a history of cigarette smoking. The mean total cholesterol level was 176.1 ± 37.3 mg/dl, the mean systolic blood pressure was 113.1 ± 13.3 mm Hg, and the mean diastolic blood pressure was 78.9 ± 9.5 mm Hg. There were 5 participants with hypertension (13.5%). Twelve (32%) participants had a history of chronic cocaine use, and 23 (62%) were HIV positive. Among the factors investigated, including age, sex, blood pressure, cigarette smoking, C-reactive protein, fasting glucose, triglycerides, serum total cholesterol, coronary calcium, cocaine use, and HIV infection, only total cholesterol was significantly associated with the presence of a lipid core. Conclusions: This study revealed an unexpectedly high rate of the presence of lipid core in carotid plaque and highlights the importance of cholesterol lowering to prevent cerebrovascular disease in this population. Further population-based studies are warranted to confirm these results.
© 2012 S. Karger AG, Basel
Black adults not only have the highest coronary artery disease mortality rate of any racial group in the United States [1,2], but they also have a nearly 40% higher adjusted incidence of ischemic stroke than white adults  and higher stroke mortality . African American populations also have a significantly greater common carotid intima-media thickness than non-Hispanic white populations [5,6,7].
It has been demonstrated that young and middle-aged blacks have a disproportionately high cardiovascular morbidity and mortality [8,9]. Although the risk factors for subclinical cerebrovascular disease have been extensively investigated in general, the factors that influence stroke in blacks, especially African American adults residing in an inner-city with lower socioeconomic status, are poorly documented. These factors are even less well understood when the effects of drug use or HIV infection are considered. According to our study, the frequency of the presence of coronary plaque was 30% in HIV-infected blacks aged 25-54 years; however, the frequency was 60% in those who used cocaine for longer than 15 years and used antiretroviral medications for more than 18 months .
Carotid plaque vulnerability to rupture has been reported to be associated with stroke and other cerebrovascular events [11,12,13] and a lipid core with a thin fibrous cap that occupies a high proportion of the plaque volume is a predominant indicator of plaque vulnerability . It has been reported that cerebral events can be precipitated by plaque rupture resulting from fibrous cap foam cell infiltration and cap thinning, similar to the mechanism of coronary plaque rupture leading to myocardial events . The objective of this study was to estimate the frequency of a lipid core and explore risk factors for its presence in asymptomatic, African American adults recruited from an inner-city clinic in Baltimore, Md., USA.
Between August 28, 2003, and May 26, 2005, 198 African American study participants from inner-city Baltimore were enrolled in an observational study of subclinical atherosclerosis as related to HIV and cocaine use. The study enrolled African American men and women with or without HIV infection and without cardiovascular diseases. The HIV-positive participants were recruited by flyers posted in and around the Johns Hopkins HIV/AIDS clinic. The remainder were individuals who had also responded to these flyers or were identified by word of mouth or because they were known to others already recruited. Inclusion criteria were age between 25 and 44 years and black race. Exclusion criteria were as follows: (1) any evidence of ischemic heart disease, based on clinical history, previous hospitalization for myocardial infarction, angina pectoris, or electrocardiographic and/or echocardiographic evidence of previous myocardial damage by ischemic heart disease; (2) any symptoms believed to be related to cardiovascular/cerebrovascular disease; (3) pregnancy, and (4) contraindications to MRI with contrast including renal failure. Clinical examinations, electrocardiograms, lipid profiles, high-sensitivity C-reactive protein tests, spiral computed tomographies for coronary calcium, and B-mode ultrasound for intima-media thickness of the internal carotid arteries were performed. Information about sociodemographic characteristics, medical history, medication use, and cocaine use behaviors was obtained by interviewer-administered questionnaires. Among these 198, 52 from the top 30th percentile of maximum carotid intima-media thickness of either the right or left internal carotid artery were selected for the internal carotid artery MRI examinations. The Committee on Human Research at the Johns Hopkins School of Medicine approved the study protocol, and all study participants provided written informed consent. All procedures used in this study were in accordance with institutional guidelines.
Sitting systolic and diastolic blood pressures were measured twice with a standard mercury sphygmomanometer. A nurse at the clinic measured the study participant's arm circumference and applied a correctly sized cuff. The participant sat quietly for 5 min, and then the nurse obtained the systolic and diastolic blood pressure measurements; a second measurement was made 3 min later. The average of the 2 readings was reported.
Venous blood samples were obtained after an overnight fast from a large antecubital vein. Serum was separated by centrifugation at 2,000 g for 15 min at 4°C and stored at -75°C until assayed. Serum lipid parameters, including total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol were directly determined with the use of a Roche Hitachi 747 analyzer (Englewood, N.J., USA).
The fasting plasma glucose was estimated by the glucose oxidase method (LX20 Synchron Pro; Beckman-Coulter Instruments, Brea, Calif., USA). The diagnosis of diabetes mellitus (fasting plasma glucose ≥126 mg/dl or 7.0 mmol/l) was based on the criteria of the American Diabetes Association .
The MRI study protocol has previously been described in detail . Briefly, MRI examinations were performed on a 1.5-tesla MRI scanner (CV/i scanner; GE Medical Systems, Milwaukee, Wisc., USA) using a dual 3-inch (7.6 cm) receive-only carotid surface coil fixed over each side of the neck.
A 3-dimensional time-of-flight MR angiogram was acquired to localize the carotid bifurcations. Three proton-density-weighted black blood images were oriented through the long axis of the bifurcation on the side selected based on thickness determined by ultrasound in advance of the MRI examinations. These images were used to position 5 T1- and T2-weighted fat-suppressed black blood images perpendicular to the area of greatest wall thickness with the middle slice traversing the most stenotic point. Black blood images were acquired using a double inversion recovery fast spin echo sequence with peripheral pulse gating. The acquired resolution was 2 × 0.54 × 0.54 mm .
Participants received an intravenous injection of 0.1 mmol/kg gadopentetate dimeglumine (Magnevist; Bayer Healthcare) at a rate of 2 ml/s through a power injector.
The 5 T1-weighted transverse black blood images were repeated 5 min after gadolinium administration with the inversion time adjusted to suppress the signal of flowing blood .
The postcontrast transverse image showing the largest lipid core area, or the thickest wall if no core was present, was analyzed using Vesselmass software (VesselMass; Division of Image Processing, Radiology Department, Leiden University Medical Center). An analyst drew lumen, lipid core (if present), and outer wall contours on this image using the software. Contours were reviewed by an experienced MRI physician. Observers were blinded to characteristics of the study population. The postcontrast image was used based on reports that gadolinium enhancement improves delineation of the lipid core and outer wall . The corresponding T2-weighted image was used to confirm lipid core delineation when questionable on the postcontrast series, and the corresponding precontrast T1-weighted image was used to confirm the lumen contour when flow artifact from gadolinium was present . The vessel wall was divided into 12 radial segments by a semiautomated feature of Vesselmass software.
We restricted our analysis for lipid core presence to those participants whose maximum wall thickness was ≥1.0 mm to ensure that small cores were not missed because of the resolution constraints of the MRI technique. No lipid cores were excluded by this restriction. SAS software (version 9.1) was used for all analyses. Categorical variables are presented as numbers and percentages, and were compared using the χ2 test. Continuous variables are expressed as mean ± SD, and were compared using Student's t test. Univariate logistic regression models were first fitted to evaluate the crude association between the presence of a lipid core and each of the factors, including age, sex, HIV infection, total serum cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, serum triglycerides, high-sensitivity C-reactive protein, cigarette smoking, alcohol use, glucose level, blood pressure, body mass index, cocaine or other illicit drug (opiates, benzodiazepines, methamphetamine) or alcohol use, and coronary calcium score, individually. Those factors that were significant at the p ≤ 0.10 level in the univariate models were put into the multiple logistic regression models to identify the factors that were independently associated with the presence of lipid core. Those variables that ceased to make significant contributions to the models were deleted in a stagewise manner, yielding the final models. A significance level was set at p < 0.05 and all p values reported were two-sided.
Of the above-mentioned 52 participants, 15 were excluded because their maximum segmental thickness by MRI was <1.0 mm. The remaining 37 participants had a mean maximum segmental thickness measurement of 1.60 ± 0.81 mm. Two sets of MRI images are presented (fig. 1, 2). Figure 1 depicts MRI images of a plaque with a lipid core and figure 2 shows a plaque without a lipid core (a simple plaque).
Demographic and clinical characteristics of the study participants are presented in table 1. Of the 37 participants in this study, 12 (32.4%) were women. The mean age was 38.7 ± 4.9 years. Seventy percent of the study participants had a history of cigarette smoking. The mean total cholesterol level was 176.1 ± 37.3 mg/dl, the mean systolic blood pressure was 113.1 ± 13.3 mm Hg, and the mean diastolic blood pressure was 78.9 ± 9.5 mm Hg. There were 5 participants with hypertension (13.5%). Thirty percent had a positive coronary artery calcium score. Among the 37 study participants, 23 (62.2%) were HIV-infected, and 12 (32.4%) were chronic cocaine users.
Of the 37 study participants, 9 (24.3%, 95% CI = 0.12-0.41) had a lipid core on the postcontrast MRI image. The frequencies of the presence of lipid core were 0.0% (0/10), 33.3% (3/9), and 33.3% (6/18) in those whose age was less than or equal to 35 years, above 35 but less or equal to 40 years, and above 40 years, respectively. The frequencies of the presence of lipid core were 24.0% (6/25) in males and 25.0% (3/12) in females.
Demographic characteristics and MRI measurements by the presence of a lipid core are presented in tables 1 and 2, respectively. As shown in table 1, among the variables investigated, only total cholesterol level was significantly associated with the presence of lipid core (p = 0.04) according to the t test. Compared with those without lipid core, those with lipid core had a significantly higher mean wall thickness (p = 0.006) and maximum wall thickness (p = 0.003).
According to univariate logistic regression analyses, only total cholesterol level in log scale (p = 0.049) was significantly associated with the presence of lipid core. Thus, the final multiple logistic regression analysis revealed that only total cholesterol level (log scale) was independently associated with the presence of lipid core. Age, sex, cigarette smoking, body mass index, triglycerides, high-sensitivity C-reactive protein, blood pressure, coronary artery calcification, HIV infection, and cocaine use were not significantly associated with the presence of lipid core (table 3).
To our knowledge, this is the first study to estimate the frequency of the presence of lipid core in carotid plaque in asymptomatic, young-to-middle-aged African American adults recruited from an inner-city clinic.
A high frequency (24%) of a lipid core in carotid plaque in this group aged 35 or older is quite disturbing. Although black adults have a higher stroke mortality than white adults, the underlying mechanisms remain poorly understood. The higher frequencies of hypertension and diabetes have been associated with the excess stroke mortality [19,20]. Furthermore, a lower socioeconomic status is associated with increased risk of stroke .
The MESA (Multi-Ethnic Study of Atherosclerosis) study has demonstrated that in those aged between 45 and 84 years with thickened carotid walls, plasma total cholesterol is independently associated with lipid core presence by MRI . Our study in much younger African American adults from the inner city also demonstrates that elevated total cholesterol levels, not other coronary artery disease risk factors, were a strong and independent predictor of the presence of lipid core with the use of high-resolution MRI. Thus, our findings can be considered evidence that blood cholesterol levels may be of prime importance for the development of the clinically important lipid-rich atherosclerotic plaque. Actually, accumulation of cholesterol plays a central role in atherogenesis . This investigation may be the first study to explore the relations between plaque lipid core detected by MRI and the major cardiovascular risk factors measured in asymptomatic, young African Americans living in an inner city.
The results of our study showed that among all the potential risk factors, including age, sex, family history of stroke, cigarette smoking, systolic blood pressure, diastolic blood pressure, high-sensitivity C-reactive protein, body mass index, fasting glucose, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and total cholesterol, only total cholesterol was independently associated with the presence of lipid core, as also reported in the MESA study .
This study has several limitations. First, the study participants were a convenience sample of a very selected population. Thus, the results must be interpreted with caution. Second, since the majority of participants were current smokers, the effects of cigarette smoking on the frequency of the presence of lipid core could not be evaluated, either individually or in combination. Third, the sample size of this study was relatively small due to limited resources. Fourth, owing to the nature of the cross-sectional design, some hidden confounding factors, such as socioeconomic status, were not adjusted for. Fifth, we did not collect any data on statin use and could not evaluate whether stain use would retard the lipid core. Furthermore, since this study was performed in African Americans living in inner-city Baltimore, some hidden risk factors in relation to the presence of lipid core could not be completely controlled for by statistical analyses.
Despite its limitations, this study's findings of an unexpectedly high rate of the presence of lipid core in carotid plaque in this asymptomatic, young-to-mid dle-aged African American adults have disturbing but important implications for the early prevention of cerebrovascular disease in this population. Future large studies confirming these findings that can be generalized to an urban, African American population are warranted.
The authors declare that they have no competing interests.
The study was supported by grants from the National Institute on Drug Abuse, National Institutes of Health (NIH R01DA 12777 and DA25524).
H. Lai, PhD, MPH
Department of Radiology, Johns Hopkins School of Medicine
600 N. Wolfe Street
Baltimore, MD 21287 (USA)
Tel. +1 410 955 2216, E-Mail firstname.lastname@example.org
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.